16 results
·
23ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
MODIFICATION TO HEDROCEL VERTEBRAL BODY REPLACEMENT, MODEL XX-YYY-ZZZZ
FDA 510(k)
FDA Class 2
·Orthopedic
ROLLO 210X20X16I/QT-HS/CONTEC
FDA UDI
AB MEDICA GROUP, S.A.·08428763041122·
MICROPOWER
FDA UDI
Conmed Corporation·20845854023799·MICROPOWER ORAL MAX HIGH SPEED DRILL, PERMANENT...
2040 Ceramic Brackets
FDA UDI
AMERICAN ORTHODONTICS CORPORATION·00190746005282·COSMETIC 20/40 UR CUSP 022 T=0 A+11 R4M
Aztec
FDA UDI
Aztecmed/Ent LLC·B87110210250·Mayo Hager Needle Holder
MICROPOWER
FDA UDI
Conmed Corporation·10845854023792·Micropower Oral Max High Speed Drill, Permanent...
PHILIPS HEARTSTART FRX
FDA Adverse Event
Malfunction
·PHILIPS NORTH AMERICA LLC·Product code MKJ·February 24, 2026
FORTAFLEX SURGICAL MESH
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
LIFECARD CF COMPACT RECORDER
FDA 510(k)
FDA Class 2
·Cardiovascular
CVC SET: 4-LUMEN 8.5FR X 20CM
FDA Adverse Event
Malfunction
·ARROW INTERNATIONAL INC·Product code DQY·March 20, 2013
MAXIMO VR
FDA Adverse Event
Death
·MEDTRONIC MED REL, INC.·Product code LWS·March 16, 2011
INRATIO
FDA Adverse Event
Malfunction
·HEMOSENSE SJ·Product code JPA·March 28, 2008
TRUE LOK PLUS LONG QUICK ADJUST STRUT
FDA Adverse Event
Injury
·ORTHOFIX SRL·Product code KTT·March 2, 2021
13C-Spirulina Gastric Emptying Breath Test (GEBT) - Product Usage: intended for use in the measurement of the rate of gastric emptying of solids and as an aid in the diagnosis of delayed gastric emptying (gastroparesis) in adult humans who are symptomatic for gastroparesis.
FDA Enforcement
Class II
·Terminated·Cairn Diagnostics·February 24, 2021
The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.
FDA Enforcement
Class II
·Terminated·Welch Allyn Protocol, Inc·January 15, 2014
Ellipse Implantable Cardioverter Defibrillators (ICDs), Model No. CD1275, CD1311, CD2275, CD2311, CD1411, CD2411 Ellipse ST Implantable Cardioverter Defibrillators (ICDs), Model No. CD1273, CD1309, CD1409, CD2273, CD2309, CD2409.
FDA Enforcement
Class II
·Terminated·St Jude Medical Cardiac Rhythm Management Division·September 10, 2014